Valeant CEO: We took an appropriate response to pricing with recent increase 1 Hour Ago At the J.P. Morgan Health Care Conference, Valeant CEO Joe Papa speaks with CNBC's Meg Tirrell about the turnaround in the company and their drug pricing strategy.